Patient EducationWhat mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
Introduction
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease which is characterized by airflow limitation that is not fully reversible [1]. Spirometry is the gold standard for the diagnosis and assessment of the disease [1]. COPD is currently the fifth leading cause of death worldwide [2], and projections for 2020 indicate further increase in global mortality, placing COPD on the third position of lethal diseases [3]. Cigarette smoking is by far the most important risk factor for COPD, and smoking cessation is the single most effective way to reduce the risk of developing COPD and to affect the outcome in patients at all stages of the disease [4], [5].
Discussing abnormal test results with smokers has been suggested as a “teachable moment” that may increase motivation to quit smoking, but there is only weak evidence to support such an approach [6]. Various studies have been performed on the efficacy of spirometry as a motivational tool for smoking cessation but their results are inconclusive [7], [8], [9]. Findings are often of limited validity because of one or more important biases such as unstandardized counselling intensity, incomparable or uncontrolled use of pharmacological aids for smoking cessation between experimental and control group, or different (or unclear) baseline levels of lung function and motivation to quit smoking [10]. A recent randomized trial clearly showed a positive effect; telling smokers their “lung age” (based on spirometry) increased the 12-month abstinence rate by 7.2%, but the mechanisms by which the intervention achieved its effect were unclear [11].
We conducted a randomized controlled trial on the efficacy of what we have termed “confrontational counselling” [12]. This is a patient-centred approach which involves confronting smokers with the consequences of their addiction (previously undiagnosed COPD) and which uses specific communication skills to identify and challenge irrational beliefs about smoking. In this article, we will use a mediation analysis to understand how exactly confrontational counselling may effect short-term abstinence from smoking (5 weeks after the target quit date). We hypothesised that confrontational counselling – through labelling with a potentially life-threatening illness status – increases risk perception and health concerns and decreases self-exempting beliefs in smokers, factors which in turn account for abstinence from smoking (see Fig. 1). Mediation analysis allows us to open up the “black box” that conceals the mechanisms of change in our intervention.
Section snippets
Methods
We used data from a randomized controlled trial comparing two active smoking cessation treatments in smokers with previously undiagnosed COPD: medium intensity confrontational counselling delivered by a respiratory nurse combined with nortriptyline for smoking cessation (experimental group) with medium intensity health education and promotion delivered by a respiratory nurse combined with nortriptyline for smoking cessation (control group). The third trial arm, “care as usual by the GP”, was
Results
A total of 116 smokers with previously undetected COPD were randomly allocated to the experimental group, 112 to the control group. The baseline characteristics are shown in Table 2. Mean baseline scores on all measures of health perceptions, quality of life, and mental health were comparable between the groups (not shown in the table), except for the subscale “physical role limitations” on the SF-36; the mean score in the experimental group was substantially higher (M = 84.1, S.D. = 30.0) than in
Discussion
We found three factors that mediated the effect of confrontational counselling on smoking cessation: self-efficacy towards successful smoking cessation, the expectation of getting a serious smoking-related disease within the next 10 years, and self-exempting beliefs towards smoking. All three mediators were independently associated with abstinence and accounted for the effect of the intervention.
The current evidence on the efficacy of spirometry as a motivational tool for smoking cessation is
Competing interest
The authors have no competing interests.
Disclosure statement
I (Daniel Kotz) confirm all patient/personal identifiers have been removed or disguised so the patient/person(s) described are not identifiable and cannot be identified through the details of the story.
Acknowledgements
The authors gratefully acknowledge the contributions of Kitty van der Meer (telephonic screening, logistics), Arja van de Voorde, Ellen de Goeij (spirometry), Marleen Vaassen, Hilde Bastiaens, Rianne Romers, Tim Sales, Karin Frambach (respiratory nurses), Mischa Aussems (validation spirometric test results), Willem de Goeij (database construction), Ger Driessen and Paula Rinkens (data cleaning), Hendrikus Boersma (pharmacist), and Arnold Kester (statistical advice). Daniel Kotz is the recipient
References (51)
- et al.
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
Lancet
(1997) - et al.
Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD)
Med Hypotheses
(2008) EuroQol: the current state of play
Health Policy
(1996)- et al.
The validity of the Hospital Anxiety and Depression Scale An updated literature review
J Psychosom Res
(2002) - et al.
Spirometry and smoking cessation advice in general practice: a randomised clinical trial
Respir Med
(2006) Effect of smoking characteristics on cognitive dissonance in current and former smokers
Addict Behav
(1994)- et al.
Cognitive dissonance in tobacco smokers
Addict Behav
(1991) - Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention...
The World Health Report. Reducing risks, promoting healthy life
(2002)- et al.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
Am J Respir Crit Care Med
(2001)
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study
J Am Med Assoc
Understanding the potential of teachable moments: the case of smoking cessation
Health Educ Res
Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature
Nicotine Tob Res
Spirometry for chronic obstructive pulmonary disease case finding in primary care?
Am J Respir Crit Care Med
Weekly versus basic smoking cessation support in primary care: a randomised controlled trial
Thorax
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial
Brit Med J
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial
BMC Public Health
Standardisation of spirometry
Eur Respir J
General considerations for lung function testing
Eur Respir J
Antidepressants for smoking cessation
Cochrane Database Syst Rev
Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis
Addiction
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
Med Care
The MOS 36-item short-form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
Med Care
Cited by (27)
Smoking cessation in smokers with chronic obstructive pulmonary disease
2014, Revue des Maladies RespiratoiresPredictive validity of the Motivation To Stop Scale (MTSS): A single-item measure of motivation to stop smoking
2013, Drug and Alcohol DependenceCitation Excerpt :Measuring motivation to stop smoking is useful in population surveys as a means of assessing the impact of interventions such as mass media campaigns, and tracking trends over time, or making comparisons between different populations or sub-populations. Different studies use different ad-hoc measures (for example: Ashraf et al., 2009; Boardman et al., 2005; George et al., 2002; Kotz et al., 2009; Tønnesen et al., 2006). It would be useful to have a standard measure that is as brief as possible and has proven validity.
Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: A comparison of smokers with and without lung impairment
2010, Patient Education and CounselingEffectiveness of the spirometry-based motivational intervention to quit smoking: RESET randomised trial
2023, European Journal of General PracticeHi, I’m Cecil(y) the Smoking Cessation Chatbot: The Effectiveness of Motivational Interviewing and Confrontational Counseling Chatbots and the Moderating Role of the Need for Autonomy and Self-efficacy
2023, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)